China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Inventory for 9 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory rose 623.83% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 623.83% YoY) and the FY2026 annual result came in at $2.2 million, up 623.83% from the prior year.
• Inventory improved to $2.2 million in Q1 2026 per SXTC's latest filing, from $1.1 million in the prior quarter.
• Over the last five years, Inventory for SXTC reached as high as $2.2 million in Q1 2026 and fell as low as $58128.0 in Q3 2022.
• A 5-year average of $753227.1 and a median of $721318.0 in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory slumped 89.11% — and 2024, when it surged 718.72%.
• Year by year, Inventory stood at $58128.0 in 2022, then surged by 51.57% to $88103.0 in 2023, then jumped by 718.72% to $721318.0 in 2024, then soared by 50.79% to $1.1 million in 2025, then jumped by 100.34% to $2.2 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $2.2 million, $1.1 million, and $301050.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.